Position in GRFS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$537,287
-$89,275 QoQ
Shares Held
75,888
-2.9% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#56
of 164 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OPPENHEIMER ASSET MANAGEMENT INC. holds $503,921,348 across 14 Drug Manufacturers - General names. GRFS ranks #13 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
584,951 | $148,560,000 | |
| 2 | LLY |
ELI LILLY & Co
|
79,471 | $95,319,902 | |
| 3 | MRK |
Merck & Co., Inc.
|
492,922 | $63,340,474 | |
| 4 | ABBV |
AbbVie Inc.
|
177,881 | $44,761,969 | |
| 5 | NVO |
Novo Nordisk A S
|
874,376 | $41,917,582 | |
| 6 | NVS |
Novartis AG
|
217,234 | $34,044,911 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
495,604 | $28,556,701 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
111,624 | $14,102,575 |
All Filings in GRFS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $537,287 | 75,888 | Shares | Other | 2026-08-03 | |
| 2026-03-31 | $626,562 | 78,125 | Shares | Other | 2026-04-24 | |
| 2025-12-31 | $651,994 | 69,732 | Shares | Other | 2026-02-02 | |
| 2025-09-30 | $630,318 | 63,285 | Shares | Other | 2025-11-06 | |
| 2025-06-30 | $569,438 | 62,991 | Shares | Other | 2025-07-31 | |
| 2025-03-31 | $427,047 | 60,063 | Shares | Other | 2025-04-23 | |
| 2024-12-31 | $268,457 | 36,083 | Shares | Other | 2025-02-05 | |
| 2024-09-30 | $521,051 | 58,677 | Shares | Other | 2024-11-05 | |
| 2024-06-30 | $352,646 | 55,887 | Shares | Other | 2024-08-08 | |
| 2024-03-31 | $238,923 | 35,767 | Shares | Other | 2024-05-07 | |
| 2023-12-31 | $418,483 | 36,201 | Shares | Other | 2024-02-13 | |
| 2023-09-30 | $336,470 | 36,813 | Shares | Other | 2023-11-08 | |
| 2023-06-30 | $354,519 | 38,703 | Shares | Other | 2023-08-03 | |
| 2023-03-31 | $294,225 | 39,922 | Shares | Other | 2023-05-10 | |
| 2022-12-31 | $245,191 | 28,846 | Shares | Other | 2023-02-07 | |
| 2022-09-30 | $270,319 | 43,883 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $509,604 | 42,896 | Shares | Other | 2022-08-08 | |
| 2022-03-31 | $504,961 | 43,233 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $339,202 | 30,205 | Shares | Other | 2022-02-02 | |
| 2021-09-30 | $568,153 | 38,888 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $556,101 | 32,052 | Shares | Other | 2021-08-03 | |
| 2021-03-31 | $379,860 | 21,970 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $305,918 | 16,590 | Shares | Other | 2021-02-11 | |
| 2020-03-31 | $6,827 | 339 | Shares | Other | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||